AZN
Price
$68.19
Change
-$0.08 (-0.12%)
Updated
Mar 28, 10:14 AM EST
28 days until earnings call
MRK
Price
$131.80
Change
+$6.26 (+4.99%)
Updated
Mar 27, 6:59 PM EST
28 days until earnings call
Ad is loading...

AZN vs MRK ᐉ Comparison: Which is Better to Invest?

Header iconAZN vs MRK Comparison
Open Charts AZN vs MRKBanner chart's image
AstraZeneca
Price$68.19
Change-$0.08 (-0.12%)
Volume$3.05K
CapitalizationN/A
Merck & Co
Price$131.80
Change+$6.26 (+4.99%)
Volume$5.14M
CapitalizationN/A
View a ticker or compare two or three
AZN vs MRK Comparison Chart

Loading...

AZNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MRKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AZN vs. MRK commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZN is a StrongBuy and MRK is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (AZN: $68.25 vs. MRK: $131.75)
Brand notoriety: AZN and MRK are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZN: 126% vs. MRK: 183%
Market capitalization -- AZN: $204.52B vs. MRK: $333.68B
AZN [@Pharmaceuticals: Major] is valued at $204.52B. MRK’s [@Pharmaceuticals: Major] market capitalization is $333.68B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.87B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZN’s FA Score shows that 2 FA rating(s) are green whileMRK’s FA Score has 3 green FA rating(s).

  • AZN’s FA Score: 2 green, 3 red.
  • MRK’s FA Score: 3 green, 2 red.
According to our system of comparison, MRK is a better buy in the long-term than AZN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZN’s TA Score shows that 7 TA indicator(s) are bullish while MRK’s TA Score has 5 bullish TA indicator(s).

  • AZN’s TA Score: 7 bullish, 3 bearish.
  • MRK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AZN is a better buy in the short-term than MRK.

Price Growth

AZN (@Pharmaceuticals: Major) experienced а +3.83% price change this week, while MRK (@Pharmaceuticals: Major) price change was +6.38% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.81%. For the same industry, the average monthly price growth was -3.02%, and the average quarterly price growth was -1.90%.

Reported Earning Dates

AZN is expected to report earnings on Apr 25, 2024.

MRK is expected to report earnings on Apr 25, 2024.

Industries' Descriptions

@Pharmaceuticals: Major (+0.81% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
A.I.dvisor published
a Summary for AZN with price predictions.
OPEN
A.I.dvisor published
a Summary for MRK with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MRK($334B) has a higher market cap than AZN($205B). MRK has higher P/E ratio than AZN: MRK (941.07) vs AZN (35.82). MRK YTD gains are higher at: 21.616 vs. AZN (2.886). AZN has higher annual earnings (EBITDA): 13.4B vs. MRK (6.91B). MRK has more cash in the bank: 7.09B vs. AZN (5.86B). AZN has less debt than MRK: AZN (28.6B) vs MRK (35.1B). MRK has higher revenues than AZN: MRK (60.1B) vs AZN (45.8B).
AZNMRKAZN / MRK
Capitalization205B334B61%
EBITDA13.4B6.91B194%
Gain YTD2.88621.61613%
P/E Ratio35.82941.074%
Revenue45.8B60.1B76%
Total Cash5.86B7.09B83%
Total Debt28.6B35.1B81%
FUNDAMENTALS RATINGS
AZN vs MRK: Fundamental Ratings
AZN
MRK
OUTLOOK RATING
1..100
7576
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
90
Overvalued
PROFIT vs RISK RATING
1..100
135
SMR RATING
1..100
5789
PRICE GROWTH RATING
1..100
5320
P/E GROWTH RATING
1..100
901
SEASONALITY SCORE
1..100
n/a38

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZN's Valuation (21) in the Pharmaceuticals Major industry is significantly better than the same rating for MRK (90). This means that AZN’s stock grew significantly faster than MRK’s over the last 12 months.

MRK's Profit vs Risk Rating (5) in the Pharmaceuticals Major industry is in the same range as AZN (13). This means that MRK’s stock grew similarly to AZN’s over the last 12 months.

AZN's SMR Rating (57) in the Pharmaceuticals Major industry is in the same range as MRK (89). This means that AZN’s stock grew similarly to MRK’s over the last 12 months.

MRK's Price Growth Rating (20) in the Pharmaceuticals Major industry is somewhat better than the same rating for AZN (53). This means that MRK’s stock grew somewhat faster than AZN’s over the last 12 months.

MRK's P/E Growth Rating (1) in the Pharmaceuticals Major industry is significantly better than the same rating for AZN (90). This means that MRK’s stock grew significantly faster than AZN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNMRK
RSI
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
55%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
57%
Momentum
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
49%
MACD
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
59%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
47%
Advances
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
50%
Declines
ODDS (%)
Bearish Trend 11 days ago
46%
Bearish Trend 15 days ago
45%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
41%
Aroon
ODDS (%)
Bullish Trend 2 days ago
48%
Bearish Trend 2 days ago
46%
View a ticker or compare two or three
Ad is loading...
AZNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MRKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GOGO8.670.34
+4.08%
Gogo
PRGO31.460.66
+2.14%
Perrigo Company PLC
PRU117.021.20
+1.04%
Prudential Financial
MVST0.84N/A
-0.07%
Microvast Holdings
BYU1.35-0.02
-1.46%
BAIYU Holdings

MRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRK has been loosely correlated with NVS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MRK jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
+4.96%
NVS - MRK
44%
Loosely correlated
+0.64%
JNJ - MRK
44%
Loosely correlated
+1.41%
GSK - MRK
39%
Loosely correlated
+0.47%
AZN - MRK
37%
Loosely correlated
+2.89%
BMY - MRK
33%
Poorly correlated
+1.33%
More